Category
Telehealth
3 articles
Telehealth Prescribing of Schedule 4 Peptides in Australia: 2026 Policy Brief
Telehealth has become a permanent fixture of Australian healthcare. Its intersection with Schedule 4 peptide prescribing — covering agents like semaglutide, tirzepatide, and emerging research peptides — remains under-examined. This brief surveys the current regulatory framework, identifies oversight gaps, and proposes reform priorities to ensure clinical safety without restricting legitimate access.
Rural and Remote Health Access in Australia: The Policy Gap That's Costing Lives
Rural Australians die on average two years younger than their city counterparts. A policy analysis of the GP workforce crisis, specialist access deserts, the MBS telehealth permanency debate, RFDS funding constraints, and the concrete reforms needed to close the gap.
Telehealth Permanency in Australia: The Case for Making COVID-Era Reforms Last
Australia's COVID-era telehealth expansion delivered measurable access gains for rural patients, mental health consumers, and specialist-deprived communities. A policy analysis of what has been made permanent, what remains under review, and why the evidence strongly supports a fully permanent tiered telehealth model.